Zymeworks (ZYME) Prices 4.925M Share Offering at $46.50/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
After-Hours Stock Movers 01/21: (NAVI) (CIT) (IBM) Higher; (NVAX) (BPMC) (ADAP) Lower (more...)
January 21, 2020 5:41 PM ESTToday's After-Hours Stock Movers:
Novavax (NASDAQ: NVAX) 15.2% LOWER; files prospectus supplement relates to the issuance and sale of up to $100,000,000 of our common stock from time to time through or to our sales agent, B. Riley FBR, Inc., or BRFBR
Navient (NASDAQ: NAVI) 6.2% HIGHER; reported Q4 EPS of $0.67, $0.10 better than the analyst estimate of $0.57.
CIT Group Inc. (NYSE: CIT) 5.8% HIGHER; will replace Tanger Factory Outlet... More
Zymeworks (ZYME) to Offer Common Stock and Pre-Funded Warrant
January 21, 2020 4:17 PM ESTZymeworks Inc. (NYSE: ZYME) filed a preliminary prospectus supplemen to its Canadian short form base shelf prospectus dated November 18, 2019 in connection with an offering of its common shares and, in lieu of common shares to a certain investor, pre-funded warrants to purchase its common shares. The Canadian Supplement was filed with the securities regulatory authorities in each of the provinces and territories of Canada. A preliminary prospectus supplement was also filed with the U.S. Securities and Exchange Commission as part of an automatic shelf registration statement on Form S-3ASR,... More
